Skip to main content
Shahid Nimjee, MD, Neurosurgery, Columbus, OH

ShahidMehdiNimjeeMDPhD

Neurosurgery Columbus, OH

Cerebrovascular Neurosurgery, Interventional Neuroradiology

Professor, Department of Neurological Surgery, The Ohio State University Wexner Medical Center

Dr. Nimjee is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Nimjee's full profile

Already have an account?

  • Office

    N-1014 Doan Hall
    410 W 10th Avenue
    Columbus, OH 43210
    Phone+1 614-293-5221
    Fax+1 614-293-4281

Summary

  • I am a Professor of Neurological Surgery at The Ohio State University Medical Center.

Education & Training

  • Duke University Hospital
    Duke University HospitalCerebrovascular/Endovascular Neurosurgery, 2012 - 2014
  • Duke University Hospital
    Duke University HospitalResidency, Neurological Surgery, 2007 - 2012
  • Duke University Hospital
    Duke University HospitalInternship, Transitional Year, 2006 - 2007
  • Duke University School of Medicine
    Duke University School of MedicineClass of 2006

Certifications & Licensure

  • OH State Medical License
    OH State Medical License 2014 - 2026
  • NC State Medical License
    NC State Medical License 2012 - 2024
  • American Board of Neurological Surgery Neurological Surgery

Awards, Honors, & Recognition

  • Member Alpha Omega Alpha Medical Honor Society, 2014

Publications & Presentations

PubMed

Journal Articles

  • Use of Antiplatelet Agents in the Neurosurgical Patient  
    Shahid Nimjee, MD, ScienceDirect
  • C2-3 Anterior Cervical Arthrodesis in the Treatment of Bow Hunter’s Syndrome: Case Report and Review of the Literature  
    Victoria Schunemann, David Dornbos, Shahid M Nimjee, World Neurosurgery

Press Mentions

  • Expanding Convergent Research: Ohio State’s Team Science Ecosystem
    Expanding Convergent Research: Ohio State’s Team Science EcosystemOctober 16th, 2024
  • Basking Biosciences Presents Positive Clinical Results from Safety and Dose-Escalation Study for First Reversible Thrombolytic Agent at ISC 2023
    Basking Biosciences Presents Positive Clinical Results from Safety and Dose-Escalation Study for First Reversible Thrombolytic Agent at ISC 2023February 9th, 2023
  • Imperative Care Announces Positive Real-World Data Showing That the Zoom Stroke Solution Achieved Superior Procedure Outcomes with Lower Cost in Ischemic Stroke Patients
    Imperative Care Announces Positive Real-World Data Showing That the Zoom Stroke Solution Achieved Superior Procedure Outcomes with Lower Cost in Ischemic Stroke PatientsJuly 26th, 2022
  • Join now to see all

Professional Memberships